This guidance addresses frequently asked questions concerning implementation of the mandatory cosmetic recall requirements.
Regulatory News
Pennsylvania enacted SB 381 (Act No. 92 of 2026), banning from January 1, 2027 the sale in the state of cosmetics using animal testing by manufacturers or their suppliers.
CIRS Group has summarized the latest global cosmetic regulatory developments of September 2026 to help enterprises gain a comprehensive view of global regulatory trends.
US FDA advised cosmetic stakeholders it will not issue cosmetic facility‑registration compliance certificates to clarify its regulatory scope and avoid market misinterpretation.
U.S. FDA issued Final Administrative Order OTC000008‑1 to remove PABA and trolamine salicylate from the sunscreen active‑ingredient list by deeming them not GRASE.
CIRS Group has compiled and summarised the latest global cosmetic regulatory developments of July 2026.
As global regulatory landscapes evolve, staying ahead of compliance deadlines is critical for beauty and personal care brands. To help companies systematically track regulatory shifts and assess compliance risks in advance, CIRS Group has compiled a comprehensive timeline of upcoming global cosmetic regulations taking effect from August 2026 onward.
Colorado Governor signed HB26-1135 which prohibits in-state sale and distribution of covered hair products with intentionally added carcinogens or reproductive toxicants effective July 1, 2027.
CIRS Group has categorized the cosmetic regulations that have already taken effect or been implemented in major global markets as of July 31, 2026 (inclusive), for your reference.
Illinois signed Chemicals in Cosmetic Products Act into law on July 10, 2026, banning cosmetics with 24 specified intentionally added ingredients starting July 1, 2028.
